LaGrippe Research, a market research firm specializing in healthcare, is inviting individuals diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), as well as family members who help support/care for a loved one diagnosed with CIDP, to participate in their research study. This will be an in-person usability study, and those who qualify will be invited to join us for a 60-minute session. During this session, respondents will be asked to make a simulated use of a device. This means they will use the device to perform an injection into an injection pad. Please note that respondents will not be taking any treatment; this is simply a simulation to gain user feedback on the device. Those who qualify and participate will be compensated for their time.
Duration: 60 minutes – 1 session
Location/Dates:
- October 15 – October 17 New York, NY
- October 21 – October 22 Atlanta, GA
- October 23 – October 26 Tampa, FL
Honorarium for participation: $125
If you are interested, please fill out our preliminary questions online below:
If you have any questions, please contact Maggie at 847-373-4104 or email maggie@lagripperesearch.com
Foundation Summary of this Opportunity:
What is the purpose of this study?
- LaGrippe Research, a market research firm specializing in healthcare, wants CIDP patients to try a new injection pad, soley for simulation. Participants will not be injected with any form of treatment.
Who is eligible for this study?
- CIDP patients and their family members
- U.S Citizens
How long will this study take to complete?
- One session is required at approximately 60 minutes
Where will this study take place?
- October 15 – 17 in New York, NY
- October 21 – 22 in Atlanta, GA
- October 23 – 26 in Tampa, FL
What is the compensation for participating?
- $125 US Dollars